While the advent of biomarker testing and targeted therapies has significantly transformed outcomes for patients with metastatic colorectal cancer, it can be challenging for multidisciplinary teams to stay abreast of the latest clinical advances in the face of ever-expanding testing and treatment possibilities. The Association of Cancer Care Centers (ACCC)—in partnership with the American Society for Clinical Pathology (ASCP) and the France Foundation—is committed to ensuring providers are equipped with the knowledge needed to apply guidelines and current research on therapeutic targets for mutations in patients with metastatic colorectal cancer as well as engage patients in shared decision-making regarding biomarker testing and treatment options.
The goal of this initiative is to provide guidance for multidisciplinary care teams on how to develop practical biomarker testing protocols for metastatic colorectal cancer and how this information can support personalized treatment decisions for improved patient outcomes.
This live workshop delivers a combination of interactive formats that allow for continuous assessment of knowledge gaps. Participants will develop a personalized action plan for incorporating new insights and competencies into practice.
Participants will engage in interactive, small-group activities, including:
Washington, D.C.
April 27, 2023
Chicago, IL
May 12, 2023
Tampa, FL
May 20, 2023
Seattle, WA
June 23, 2023
Houston, TX
September 22, 2023
Philadelphia, PA
October 20, 2023
Atlanta, GA
November 11, 2023
Detroit, MI
December 9, 2023
Register Now
This activity is jointly provided by The France Foundation, American Society for Clinical Pathology, and Association of Cancer Care Centers.
This activity will award AMA PRA Category 1 Credit(s)™ and nursing contact hours.
For additional CE information, please visit tffevents.com/crc.